癌变·畸变·突变 ›› 2025, Vol. 37 ›› Issue (3): 215-220.doi: 10.3969/j.issn.1004-616x.2025.03.007

• 论著 • 上一篇    

复方丹参制剂对伊马替尼在大鼠体内代谢的影响

范娜灵, 郭雅, 郭腾, 刘明峰, 杜丽英, 陈欣然   

  1. 河北医科大学第四医院药学部, 河北省临床药学重点实验室, 河北 石家庄 050011
  • 收稿日期:2024-12-18 修回日期:2025-04-22 发布日期:2025-06-13
  • 通讯作者: 陈欣然
  • 作者简介:范娜灵,E-mail:a2059848705@163.com。
  • 基金资助:
    河北省科学技术厅民生科技专项(20377757D)

Effect of Danshen preparation on blood concentration of imatinib in rats

FAN Naling, GUO Ya, GUO Teng, LIU Mingfeng, DU Liying, CHEN Xinran   

  1. Hebei Key Laboratory of Clinical Pharmacy, Department of Pharmacy, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, China
  • Received:2024-12-18 Revised:2025-04-22 Published:2025-06-13

摘要: 目的:探讨复方丹参制剂对伊马替尼和N-去甲基伊马替尼在大鼠体内代谢的影响。方法:将30只健康雄性SD大鼠随机分为3组,分别为对照组、复方丹参片组和复方丹参滴丸组。3组均按30 mg/kg给予伊马替尼,此外复方丹参片组和复方丹参滴丸组分别按486和72.9 mg/kg给药,各组均连续灌胃14 d。分别在灌胃后第1和第14天采集大鼠血浆样品,采用超高效液相色谱-质谱联用技术(HPLC-MS/MS)测定血浆中伊马替尼和N-去甲基伊马替尼的浓度。利用DAS2.0软件计算伊马替尼与N-去甲基伊马替尼的药动学参数。结果:与对照组比较,给药后第1天,复方丹参片组大鼠的伊马替尼药时曲线下面积(AUC0-∞)降低了19.00%(P<0.05);给药后第14天,复方丹参片组大鼠的伊马替尼AUC0-24和峰浓度(Cmax)分别降低了19.45%和17.84%(P<0.05),且N-去甲基伊马替尼的AUC0-24和AUC0-∞分别降低了29.87%和35.27%(P<0.05)。给药后第1天和第14天,复方丹参滴丸组伊马替尼和N-去甲基伊马替尼的药动学参数与对照组比较差异均无统计学意义(P>0.05)。结论:复方丹参片可能影响伊马替尼给药后大鼠的血药浓度,而复方丹参滴丸对大鼠血浆中伊马替尼和N-去甲基伊马替尼的浓度无明显影响。

关键词: 伊马替尼, N-去甲基伊马替尼, 复方丹参片, 复方丹参滴丸

Abstract: OBJECTIVE: This study aimed to investigate effect of Danshen (Salvia miltiorrhiza) preparation on blood concentration of imatinib and N-desmethyl imatinib in rats. METHODS: Healthy male SD rats were randomly divided into three groups of 10 per group:control,Danshen tablet of 486 mg/kg and Danshen dripping pill of 72.9 mg/kg. All three groups were given imatinib at 30 mg/kg. Each group was given by intragastric administration for 14 consecutive days. Plasma samples were collected on day 1 and day 14. Blood concentrations of imatinib and N-desmethyl imatinib were determined by ultra-performance liquid chromatography-mass spectrometry (HPLC-MS/MS). Calculation of pharmacokinetic parameters of imatinib and N-desmethyl imatinib using DAS 2.0 software. RESULTS: On the 1st day after administration,the area under the concentration-time curve (AUC0-∞) of imatinib in the compound Danshen tablet group was reduced by 19.00% (P<0.05) compared with the control group. On the 14th day after administration,the AUC0-24 and peak concentration (Cmax) of imatinib in the compound Danshen tablet group were reduced by 19.45% and 17.84%, respectively (P<0.05). The AUC0-24 and AUC0-∞ of N-desmethylimatinib were reduced by 29.87% and 35.27%, respectively (P<0.05). On the 1st and 14th days after administration,there were no significant differences in the pharmacokinetic parameters of imatinib and N-desmethylimatinib between the compound Danshen dripping pill group and the control group (P>0.05). CONCLUSION: Compound Danshen tablets affected the plasma concentrations of imatinib in rats while compound Danshen dripping pills had no significant effect on the concentrations of imatinib and N-desmethylimatinib in rat plasma.

Key words: imatinib, N-desmethyl imatinib, compound Danshen tablet, compound Danshen drip pill

中图分类号: